-
Model parameters.
aSpecified with reference to Cook [30] and Waage et al. [36] using distributions defined in Biosecurity Australia [31]; b Derived from Sapoukhina et al. [37]; c ABS [6], Note... -
Results of sensitivity analysis.
Effect of changing each parameter over its range on estimated cost effectiveness of base case programme (estimates derived from regression model). 95% end points of range of... -
Oligonucleotides used in this study.
aSequences in upper case letters are derived from the genome sequences of H. pylori 26695 [25], H. hepaticus[32], C. jejuni[33] and W. succinogenes[34]. Sequences introduced for... -
Summary statistics.
Values are presented as Mean ±SEM. Abbreviations: fWHR [34]; EME [44]; ULh, LLh and Nw [33]; Index 1 [47], Index 2 [48], [50], Index 3 [10], [49], ProcDist [54], [79], DiscSco1... -
dedup_wf_001--c8242207ebc7b7fba7701b9ceadaa448
E/C: E mean experimental group, C mean control group Pattern: teaching pattern, PBL mean PBL teaching model alone in experimental group, PBL+LBL mean PBL+LBL teaching model in... -
Study characteristics.
*other than SAA: MAA or not reported degree of severity. †other than first-line MRD: second-line HSCT, first-line mismatched related HSCT, first-line- unrelated HSCT.‡Fouladi... -
Baseline characteristics of patients.
ap-value comparing normal pulmonary function and abnormal pulmonary function groups. bp-value according to one-way ANOVA comparing patients with normal pulmonary function,... -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of...
